CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $15,593,000 | +7.0% | 2,147,797 | -4.2% | 0.00% | 0.0% |
| Q3 2016 | $14,578,000 | +19.5% | 2,242,700 | +0.4% | 0.00% | 0.0% |
| Q2 2016 | $12,197,000 | +2.5% | 2,233,885 | -12.2% | 0.00% | 0.0% |
| Q1 2016 | $11,904,000 | -6.2% | 2,543,547 | -0.2% | 0.00% | 0.0% |
| Q4 2015 | $12,689,000 | +36.7% | 2,547,894 | +3.2% | 0.00% | 0.0% |
| Q3 2015 | $9,279,000 | -37.9% | 2,467,793 | -0.7% | 0.00% | 0.0% |
| Q2 2015 | $14,933,000 | +9.5% | 2,484,644 | +2.0% | 0.00% | 0.0% |
| Q1 2015 | $13,640,000 | +90.1% | 2,435,646 | +1.8% | 0.00% | +100.0% |
| Q4 2014 | $7,176,000 | +12.1% | 2,392,123 | +0.1% | 0.00% | 0.0% |
| Q3 2014 | $6,404,000 | -1.9% | 2,389,631 | +2.5% | 0.00% | 0.0% |
| Q2 2014 | $6,526,000 | -35.6% | 2,330,742 | +0.3% | 0.00% | -50.0% |
| Q1 2014 | $10,135,000 | +46.8% | 2,324,499 | +8.1% | 0.00% | +100.0% |
| Q4 2013 | $6,903,000 | +107.2% | 2,150,366 | +2.6% | 0.00% | 0.0% |
| Q3 2013 | $3,332,000 | -8.0% | 2,095,507 | +0.1% | 0.00% | 0.0% |
| Q2 2013 | $3,623,000 | – | 2,094,244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |